// App-Quantinova.ai

491 : Does Partial Donor Chimerism (PDC) Increase the Risk of Relapse in Pediatric Patients with Leukemia Undergoing Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT)

Researchers

Presenter

  • Sana Khan

Principal Investigators

  • Reggie E Duerst

  • William T Tse

  • Jennifer Schneiderman

  • Sonali Chaudhury

  • Morris Kletzel

Medical Centers

  • Pediatric Hematology/Oncology/Transplant, Ann and Robert h. Lurie Childrens Hospital of Chicago, Chicago, IL

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • Hem-Onc-Transplant Division, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL

  • Hematology/Oncology/Transplant, Ann & Robert Lurie Childrens Hospital of Chicago, Northwestern University, Feinberg School of Medicine, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • fludarabine tablet

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved